627-90-7 | Sigma-Aldrich

Data Sheet - A7011

J. Biol. Chem., 268, 7792-7798 (1993). 10. Heitz, J.R., et al., Arch. Biochem. Biophys., 127, 627-636 (1968). 11. Vallee, B.L., and Hoch, F.L., PNAS, USA, 41, 327- 338 (1955). RC,GY,PHC 01/14

Data Sheet - S1186

Phillips, N. E., and Parker, D. C., J. Immunol., 132, 627-632 (1984). 6. Choquet, D., et al., J. Cell Biol., 121, 355-363 (1993). 7. Tridandapani, S., et al., J. Immunol., 158, 1125- 1132 (

GenElute-E Single SpinTissue DNA Kit

of samples 1 6 (+10%) 12 (+10%) Tissue Lysis Buffer 90 µL 594 µL 1,188 µL SmartLyse™ T Protease 5 µL 33 µL 66 µL Final Volume 95 µL 627 µL 1,254 µL 3. Place the

Quick start Guide- EC300

of samples 1 6 (+10%) 12 (+10%) Tissue Lysis Buffer 90 µL 594 µL 1,188 µL SmartLyse™ T Protease 5 µL 33 µL 66 µL Final Volume 95 µL 627 µL 1,254 µL 3. Place the

N27 Rat Dopaminergic Neural Cell Line

medium. 7. Plate cells to T75 flask, culture cells at 5% CO2, 37°C tissue culture incubator. 8. Change medium every day. 9. Cells are ready to be passage upon 70-90%

XP725 Antibody Number-Lot Number 071M4826

.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80 1.3 9 10 11 12 33 34 35 36 57 58 59 60 81 82 83 84 1.4 13 14 15 16 37 38 39

Anti-NeuN, clone A60 - Data Sheet

-1171. 3) Nature (1996) 383:624-627. 4) J. Neuroscience (1997) 17:5820-5829. 5) J. Neuroscience (1997) 17:7415-7424. 6) J. Neuroscience (1998) 18:3206-3212. 7) J. Neuroscience (1998) 18:5614-5629

User Manual - EC300

of samples 1 6 (+10%) 12 (+10%) Tissue Lysis Buffer 90 µL 594 µL 1,188 µL SmartLyse™ T Protease 5 µL 33 µL 66 µL Final Volume 95 µL 627 µL 1,254 µL 3. Place the

GenElute-E Single SpinTissue DNA Kit

of samples 1 6 (+10%) 12 (+10%) Tissue Lysis Buffer 90 µL 594 µL 1,188 µL SmartLyse™ T Protease 5 µL 33 µL 66 µL Final Volume 95 µL 627 µL 1,254 µL 3. Place the

MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors

4800 2477 Rat 2 269 1971 152 Rat 3 627 2948 Rat 4 4725 2732 Mouse 1 11 8 Mouse 2 3715 208 157 50 7102 Mouse 3 1615 82 61 36 8665

Article: Virus filtration process development optimization

.0 area ratio (lower left graphs, Figure 7 and Figure 8) to the freshness of Feed 3 (hours old rather than days). Feed 2 at pH 6.5 achieved 400-L/m2 with 90% flow decay, whereas Feed 3 at pH 6.5

Drug Discovery Products & Services - Volume 1, 2014

Log10 (M) Compound ATM vs Inhibitors -11 -10 -9 -8 -7 -6 -5 -4 -3 0 10 20 30 40 50 60 70 80 90 100 110 120 KU-55933 PI-103 PIK-90 % A ct iv ity Ataxia telangiectasia mutated

BioFiles-Issue

Lissamine, Alexa 555 Atto 590 598 634 80 120000 HeNe laser Texas Red, Alexa 594 Atto 594 601 627 85 120000 HeNe laser Texas Red, Alexa 594 Atto 610 605 646 70

Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy

Roth, S.Y., Curr. Opin. Genet. Dev., 11, 155-161 (2001). 16. Kuo, M.H., et al., Genes Dev., 12, 627-639 (1998). 17. Wang, L., et al., Genes Dev., 12, 640-653 (1998). 18. Grant, P.A., et al., Cell

Material Matters Vol. 1, No. 1

et al. Biosens. Bioelectron. �00�, 17, 53. (6) Brahim, S. et al. Electroanalysis. �00�, 14(9), 627. (7) Rubio Retama, J. et al. Biosens. Bioelectron. �004, 20, 1111. (8) Brahim, S. et al. Microchimica

Magna ChIP™ HT96

hm en t Antibody Performance Using Magna ChIP HT96 Panel II 1 84 108 133 212 627 1219 1935 0 500 1000 1500 2000 2500 C on

EZ-Magna ChIP™ HT96 (Cat. No. 17-10078)

hm en t Antibody Performance Using Magna ChIP HT96 Panel II 1 84 108 133 212 627 1219 1935 0 500 1000 1500 2000 2500 C on

Magna ChIP™ HT96 (Cat. No. 17-10077)

hm en t Antibody Performance Using Magna ChIP HT96 Panel II 1 84 108 133 212 627 1219 1935 0 500 1000 1500 2000 2500 C on

Advanced Applications of Engineered Nanomaterials

regiorandom) ��90�7 (electronic grade) -3.2 eV -5.1 eV PCBM n-type �591�9 -3.7 eV -6.1 eV Prod. No. Fullerene Type Structure ��818� N-methylfulleropyrrolidine (MP-C60) N CH3 �588�7 (1,2

JULABO Catalog 2011 en

5 and 7 liters Plexiglas®: to +60 °C (designated 'A') Makrolon®: to +100 °C (designated 'M') | MB-7A| ED-5A | ED-5M 41 20 40 8060 30

An Update on Ligands for Prostanoid Receptors

, 1278-1284 (1999). 69. Chang, C.S., et al., Prostaglandins, 53, 83-90 (1997). 70. Whittle, B.J., et al., Prostaglandins, 19, 605-627 (1980). 71. Skuballa, W., Vorbruggen, H., Adv. Prost. Thromb. Leukot

Panorama Human Protein Functional Array-Signal Transduction

BCL2A1 BCL2-related protein A1 597 BDNF brain-derived neurotrophic factor, transcript variant 5 627 BIRC2 baculoviral IAP repeat-containing 2 329 BIRC3 baculoviral IAP repeat-containing protein

Katalog neoLab

. . . . .90 7-2020 . . . . . . . . . . . . . . . . .369 7-2100 to 7-2102 . . . . . . . . .163 7-2125. .

White Paper - The Message in the Marks: Deciphering Cancer Epigenetics

Ser137) 09-018 Anti-ubiquityl-Histone H2A , clone E6C5 05-678 Histone H2A.X Anti-Histone H2A.X 07-627 Anti-phospho Histone H2A.X (Tyr142) 07-1590 Anti-phospho-Histone H2A.X (Ser139) , clone JBW301

Brochure: LC-MS Contaminants

spectrometry” Bernd O. Keller, Jie Sui, Alex B. Young and Randy M. Whittal Analytica Chimica Acta 627, Issue 1, 3 October 2008, Pages 71-81. However, we have updated the masses listed in the previous

Biowire Fall 2010 - Breakthroughs in Biology

representative MAPs is related to loading volume of plasma samples. >90% of all 10 MAPs can be depleted from 50 µL human plasma. Figure 7. run-to-run depletion consistency of supermix columns Three

XP725 Antibody List Lot 129K4831

5747 PTK2 P NP_001186578.1 y y y 266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y 627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d 556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y 623

XP725 Antibody List Lot 129K4830

5747 PTK2 P NP_001186578.1 y y y 266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y 627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d 556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y 623

XP725 Antibody List Lot 089K4791

5747 PTK2 P NP_001186578.1 y y y 266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y 627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d 556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y 623

LC-MS Contaminants: Avoid, identify, mimimize.

spectrometry” Bernd O. Keller, Jie Sui, Alex B. Young and Randy M. Whittal Analytica Chimica Acta 627, Issue 1, 3 October 2008, Pages 71-81. However, we have updated the masses listed in the previous